Amylyx Pharmaceuticals (AMLX) Shares Outstanding (Entity) (2021 - 2026)

Amylyx Pharmaceuticals (AMLX) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Entity.) (Qtr)
1	Haleon	86.50 Bn	85.53 Bn	-	4.41 Bn
2	Teva Pharmaceutical Industries	42.71 Bn	39.05 Bn	2.15 Bn	1.17 Bn
3	Zoetis	30.86 Bn	29.18 Bn	1.80 Bn	414.15 Mn
4	Takeda Pharmaceutical	28.50 Bn	22.70 Bn	5.10 Bn	-
5	United Therapeutics	22.06 Bn	19.40 Bn	683.80 Mn	42.68 Mn
6	Viatris	18.84 Bn	17.95 Bn	1.46 Bn	1.15 Bn
7	Neurocrine Biosciences	15.55 Bn	15.16 Bn	935.80 Mn	101.60 Mn
8	Vireo Growth	11.86 Bn	11.71 Bn	59.30 Mn	1.06 Bn
9	Elanco Animal Health	11.77 Bn	11.24 Bn	798.00 Mn	499.55 Mn
10	Amylyx Pharmaceuticals	3.91 Bn	3.91 Bn	-	111.37 Mn

Download Data